Quarterly report pursuant to Section 13 or 15(d)

Condensed Statement of Operations (Unaudited)

v3.21.2
Condensed Statement of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Oct. 03, 2021
Sep. 30, 2020
Oct. 03, 2021
Sep. 30, 2020
Operating Expenses:        
Cost of revenue $ 104 $ 1,153 $ 1,847 $ 2,382
Research and development 10,301 3,807 25,413 9,442
Selling, general and administrative 8,791 1,486 17,500 3,766
Total operating expenses 19,196 6,446 44,760 15,590
Loss from operations (19,196) (6,446) (44,760) (15,590)
Other income (expense):        
Changes in fair value of convertible preferred stock warrants and common stock warrants 8,460 (7,031) 3,679 (6,756)
Issuance of convertible preferred stock warrants (non-cash) 0 0 0 (1,476)
Change in fair value of convertible promissory notes 0 0 0 (2,422)
Interest expense, net (52) 0 (187) (107)
Other (expense) income, net (50) 1 (38) 43
Total other (expense) income, net 8,358 (7,030) 3,454 (10,718)
Net loss $ (10,838) $ (13,476) $ (41,306) $ (26,308)
Net loss per share, basic $ (0.08) $ (0.16) $ (0.38) $ (0.35)
Weighted average number of common shares outstanding, basic 133,492,216 85,637,835 109,317,614 76,167,628
Net loss per share, diluted $ (0.14) $ (0.16) $ (0.45) $ (0.35)
Weighted average number of common shares outstanding, diluted 135,052,128 85,637,835 109,854,540 76,167,628